Drug comparisons
Ertugliflozin vs Repaglinide
Compare Ertugliflozin (SGLT2 inhibitor) and Repaglinide (meglitinide) for type 2 diabetes. Review mechanisms, side effects, hypoglycemia risk and suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when choosing add-on therapy after metformin for type 2 diabetes patients needing either SGLT2 benefits or prandial insulin stimulation.
Bottom line
Ertugliflozin often provides broader benefits than Repaglinide but individual factors and safety profiles determine the better option.
All medication comparisons